These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 30926258)

  • 1. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management.
    International Hypoglycaemia Study Group
    Lancet Diabetes Endocrinol; 2019 May; 7(5):385-396. PubMed ID: 30926258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized.
    Nirantharakumar K; Marshall T; Kennedy A; Narendran P; Hemming K; Coleman JJ
    Diabet Med; 2012 Dec; 29(12):e445-8. PubMed ID: 22937877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
    Freemantle N; Danchin N; Calvi-Gries F; Vincent M; Home PD
    Diabetes Obes Metab; 2016 Feb; 18(2):152-8. PubMed ID: 26511332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.
    ; Mellbin LG; Rydén L; Riddle MC; Probstfield J; Rosenstock J; Díaz R; Yusuf S; Gerstein HC
    Eur Heart J; 2013 Oct; 34(40):3137-44. PubMed ID: 23999452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of differing glucose-lowering regimens on the pattern of association between glucose control and survival.
    Currie CJ; Holden SE; Jenkins-Jones S; Morgan CL; Voss B; Rajpathak SN; Alemayehu B; Peters JR; Engel SS
    Diabetes Obes Metab; 2018 Apr; 20(4):821-830. PubMed ID: 29119713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of major cardiovascular events, severe hypoglycaemia, and all-cause mortality for users of insulin degludec versus insulin glargine U100-A Danish cohort study.
    Jensen MH; Hejlesen O; Vestergaard P
    Diabetes Metab Res Rev; 2020 Jan; 36(1):e3225. PubMed ID: 31647163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.
    Bonds DE; Miller ME; Bergenstal RM; Buse JB; Byington RP; Cutler JA; Dudl RJ; Ismail-Beigi F; Kimel AR; Hoogwerf B; Horowitz KR; Savage PJ; Seaquist ER; Simmons DL; Sivitz WI; Speril-Hillen JM; Sweeney ME
    BMJ; 2010 Jan; 340():b4909. PubMed ID: 20061358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypoglycemia and cardiovascular risk].
    Avogaro A
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):4S-12S. PubMed ID: 25623545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes.
    Nyström T; Bodegard J; Nathanson D; Thuresson M; Norhammar A; Eriksson JW
    Diabetes Obes Metab; 2017 Jun; 19(6):831-841. PubMed ID: 28116795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycaemia: an overview.
    Graveling AJ; Frier BM
    Prim Care Diabetes; 2009 Aug; 3(3):131-9. PubMed ID: 19782016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study.
    Zaccardi F; Ling S; Lawson C; Davies MJ; Khunti K
    Diabetologia; 2020 Oct; 63(10):2129-2139. PubMed ID: 32728893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
    Östgren CJ; Sundström J; Svennblad B; Lohm L; Nilsson PM; Johansson G
    Diabet Med; 2013 May; 30(5):e170-7. PubMed ID: 23350893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Devoting attention to glucose variability and hypoglycaemia in type 2 diabetes.
    Rutter MK
    Diabetologia; 2018 Jan; 61(1):43-47. PubMed ID: 28913602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
    Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
    Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.
    Boussageon R; Bejan-Angoulvant T; Saadatian-Elahi M; Lafont S; Bergeonneau C; Kassaï B; Erpeldinger S; Wright JM; Gueyffier F; Cornu C
    BMJ; 2011 Jul; 343():d4169. PubMed ID: 21791495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.
    Pieber TR; Marso SP; McGuire DK; Zinman B; Poulter NR; Emerson SS; Pratley RE; Woo V; Heller S; Lange M; Brown-Frandsen K; Moses A; Barner Lekdorf J; Lehmann L; Kvist K; Buse JB;
    Diabetologia; 2018 Jan; 61(1):58-65. PubMed ID: 28913543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A summary of the ADVANCE Trial.
    Heller SR;
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S357-61. PubMed ID: 19875581
    [No Abstract]   [Full Text] [Related]  

  • 19. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardiovascular and metabolic outcomes in people with type 2 diabetes on insulin versus non-insulin glucose-lowering therapies (GLTs): A systematic review and meta-analysis of clinical trials.
    Anyanwagu U; Mamza J; Donnelly R; Idris I
    Diabetes Res Clin Pract; 2016 Nov; 121():69-85. PubMed ID: 27662041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.